公司新闻(英文)
January 31, 2018 / 12:43 PM / 10 months ago

BRIEF-Protalix Biotherapeutics' Pegunigalsidase Alfa Receives Fast Track Designation From FDA

1 分钟阅读

Jan 31 (Reuters) - Protalix Biotherapeutics Inc:

* PROTALIX BIOTHERAPEUTICS’ PEGUNIGALSIDASE ALFA RECEIVES FAST TRACK DESIGNATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below